ETFs & Funds
Any ideas what's hammering $
Probably the study drug assignment errors in the BENEFIT-ALS trial that they mentioned in their Q2 results yesterday evening...
That was old news a week or two ago.
Canaccord Genuity Conference Transcript @
Add a reply...
Latest StockTalks »
people get CYTK breaking news and analysis by email alert.
Get email alerts on CYTK »
Get latest price
From other sites
Cytokinetics (CYTK) Looks Good: Stock Adds 6.8% in Session
at Zacks.com (Jun 16, 2016)
Should You Buy Cytokinetics (CYTK) Ahead of Earnings?
at Zacks.com (Feb 12, 2016)
Cytokinetics (CYTK) Looks Good: Stock Moves 8.8% Higher
at Zacks.com (Dec 3, 2015)
Can Cytokinetics (CYTK) Run Higher on Strong Earnings Estimate Revisions?
at Zacks.com (Nov 23, 2015)
Cytokinetics (CYTK) Shares March Higher, Can It Continue?
at Zacks.com (Nov 18, 2015)